Page last updated: 2024-09-05

erlotinib hydrochloride and Necrolytic Migratory Erythema

erlotinib hydrochloride has been researched along with Necrolytic Migratory Erythema in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, CY; Ma, SH1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Necrolytic Migratory Erythema

ArticleYear
Necrolytic migratory erythema-like eruption associated with erlotinib in a patient with lung adenocarcinoma.
    Lung cancer (Amsterdam, Netherlands), 2020, Volume: 148

    Topics: Adenocarcinoma of Lung; Erlotinib Hydrochloride; Exanthema; Humans; Lung Neoplasms; Necrolytic Migratory Erythema; Necrosis

2020